Adenomatous Polyposis Coli Completed Phase 2 Trials for Sirolimus (DB00877)

Also known as: Polyposis Coli / Familial Polyposis / Familial adenomatous polyposis

IndicationStatusPhase
DBCOND0031638 (Adenomatous Polyposis Coli)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03095703Sirolimus and Familial Adenomatous Polyposis (FAP)Treatment